Morgan Stanley Q4 Earnings Beat on IB Strength, Decent Trading Gains

15.01.26 15:31 Uhr

Werte in diesem Artikel
Aktien

1,50 USD 0,00 USD 0,00%

162,82 EUR -1,72 EUR -1,05%

Indizes

PKT PKT

18.749,1 PKT 2,7 PKT 0,01%

3.433,7 PKT -4,4 PKT -0,13%

6.940,0 PKT -4,5 PKT -0,06%

Morgan Stanley’s MS fourth-quarter 2025 earnings of $2.68 per share easily outpaced the Zacks Consensus Estimate of $2.41. Also, the bottom line jumped 21% from the prior-year quarter.Unlike its Wall Street peers, Morgan Stanley’s investment banking (IB) business gained from a frenzy of deal-making activities and IPOs. Advisory fees soared 45% year over year as completed M&A transactions rose. Further, higher issuances supported the company’s fixed income underwriting fees, which jumped 93%. Moreover, equity underwriting income grew 9% as higher convertibles and IPOs offered support. Hence, total IB fees (in the Institutional Securities division) surged 47% to $2.41 billion. Similarly, MS posted a decent trading performance. Equity trading revenues climbed 10% year over year to $3.67 billion, while fixed-income trading income was down 9% to $1.76 billion. The performance of the company’s wealth management and investment management businesses was impressive, driven by a rise in client assets and assets under management. Morgan Stanley’s net interest income (NII) increased, given the improved lending activities. On the other hand, an increase in total non-interest expenses was the undermining factor.Net income applicable to common shareholders was $4.25 billion, increasing 19% from the year-ago quarter.Morgan Stanley’s Revenues Rise, Expenses UpQuarterly net revenues were $17.89 billion, growing 10% from the prior-year quarter. The top line handily beat the Zacks Consensus Estimate of $17.32 billion.NII was $2.86 billion, up 12%. Total non-interest revenues of $15.03 billion increased 10%. Total non-interest expenses were $12.11 billion, up 8%. Provision for credit losses was $18 million compared with $115 million in the prior-year quarter.Morgan Stanley’s Segment Quarterly PerformanceInstitutional Securities: Pre-tax income was $2.66 billion, up 9% from the prior-year quarter. Net revenues were $7.93 billion, rising 9% year over year. The upside resulted from increased equity trading revenues and higher IB net revenues, partially offset by lower fixed income trading income. Wealth Management: Pre-tax income totaled $2.64 billion, surging 29% year over year. Net revenues were $8.43 billion, up 13%, driven by higher asset management revenues, transactional revenues and NII. Total client assets were $7.38 trillion as of Dec. 31, 2025, up 19% year over year. Investment Management: Pre-tax income was $468 million, climbing 13% from the year-ago quarter. Net revenues were $1.72 billion, growing 5%. The improvement was attributable to a rise in asset management and related fees, partially offset by performance-based income and other revenues. As of Dec. 31, 2025, total assets under management or supervision were $1.9 trillion, up 14% year over year.Morgan Stanley’s Capital Position SolidAs of Dec. 31, 2025, book value per share was $64.37, up from $58.98 in the corresponding period of 2024. The tangible book value per share was $50, up from $44.87 as of Dec. 31, 2024.Morgan Stanley’s Tier 1 capital ratio (advanced approach) was 18% compared with 17.8% in the year-ago quarter. The common equity Tier 1 capital ratio was 16.1% compared with 15.7% a year ago.Update on Morgan Stanley’s Share Buyback PlanIn the reported quarter, Morgan Stanley repurchased 9 billion shares for $1.5 billion.Our Viewpoint on Morgan StanleyThe solid performance of the IB business and an impressive deal-making pipeline are expected to support Morgan Stanley’s financials. Efforts to become less dependent on capital markets-driven revenues and inorganic expansion/strategic alliances will boost top-line growth. However, elevated expenses due to expansion efforts and volatile trading revenues are concerns. Morgan Stanley Price, Consensus and EPS Surprise Morgan Stanley price-consensus-eps-surprise-chart | Morgan Stanley QuoteCurrently, Morgan Stanley carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Performance of Morgan Stanley’s PeersJefferies Financial Group’s JEF fourth-quarter fiscal 2025 (ended Nov. 30) adjusted earnings from continuing operations of 96 cents per share grew 5.5% year over year. The Zacks Consensus Estimate for earnings was 83 cents.JEF’s results were aided by strong performance and sustained momentum in Investment Banking and Equities, partially offset by lower net revenues in Fixed Income and Asset Management. However, higher expenses remain a spoilsport.Solid trading performance and higher NII drove JPMorgan’s JPM fourth-quarter 2025 adjusted earnings of $5.23 per share. The bottom line handily surpassed the Zacks Consensus Estimate of $5.01.JPM’s markets revenues exceeded management's expectations and grew 17% year over year. Further, the company recorded an increase in NII, driven by higher yields and 11% year-over-year jump in total loans. However, weak IB performance and higher operating expenses and provisions weighed on the results.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report JPMorgan Chase & Co. (JPM): Free Stock Analysis Report Morgan Stanley (MS): Free Stock Analysis Report Jefferies Financial Group Inc. (JEF): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Morgan Stanley und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf CGI Group

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CGI Group

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Morgan Stanley

Wer­bung

Analysen zu Morgan Stanley

DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
20.04.2021Morgan Stanley kaufenCredit Suisse Group
DatumRatingAnalyst
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
20.04.2021Morgan Stanley kaufenCredit Suisse Group
15.10.2020Morgan Stanley OutperformRBC Capital Markets
05.10.2020Morgan Stanley OutperformRBC Capital Markets
DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
02.04.2020Morgan Stanley neutralDeutsche Bank AG
21.01.2020Morgan Stanley NeutralCitigroup Corp.
04.04.2019Morgan Stanley HoldHSBC
DatumRatingAnalyst
20.01.2016Morgan Stanley SellSociété Générale Group S.A. (SG)
25.07.2011Morgan Stanley underperformRBC Capital Markets
02.10.2009Morgan Stanley underperformCalyon Securities Inc.
31.08.2005Morgan Stanley underweightPrudential Financial
28.07.2005Morgan Stanley underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Morgan Stanley nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen